CH519507A - Verfahren zur Herstellung von neuem 1-Veratryl-4-methyl-5-äthyl-7,8-dimethoxy-2,3-diazabicyclo(5.4.0)-undecapentaen-(1,3,6,8,10) - Google Patents

Verfahren zur Herstellung von neuem 1-Veratryl-4-methyl-5-äthyl-7,8-dimethoxy-2,3-diazabicyclo(5.4.0)-undecapentaen-(1,3,6,8,10)

Info

Publication number
CH519507A
CH519507A CH1721067A CH1721067A CH519507A CH 519507 A CH519507 A CH 519507A CH 1721067 A CH1721067 A CH 1721067A CH 1721067 A CH1721067 A CH 1721067A CH 519507 A CH519507 A CH 519507A
Authority
CH
Switzerland
Prior art keywords
undecapentaen
veratryl
diazabicyclo
dimethoxy
ethyl
Prior art date
Application number
CH1721067A
Other languages
English (en)
Inventor
Jeno Dr Korosi
Lang Tibor
Endre Dr Komlos
Lujza Dr Erdelyi
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of CH519507A publication Critical patent/CH519507A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
CH1721067A 1966-12-09 1967-12-08 Verfahren zur Herstellung von neuem 1-Veratryl-4-methyl-5-äthyl-7,8-dimethoxy-2,3-diazabicyclo(5.4.0)-undecapentaen-(1,3,6,8,10) CH519507A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUGO001000 1966-12-09

Publications (1)

Publication Number Publication Date
CH519507A true CH519507A (de) 1972-02-29

Family

ID=10996660

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1721067A CH519507A (de) 1966-12-09 1967-12-08 Verfahren zur Herstellung von neuem 1-Veratryl-4-methyl-5-äthyl-7,8-dimethoxy-2,3-diazabicyclo(5.4.0)-undecapentaen-(1,3,6,8,10)

Country Status (9)

Country Link
US (1) US3736315A (de)
AT (3) AT279617B (de)
BE (1) BE707730A (de)
CH (1) CH519507A (de)
DE (1) DE1670642C3 (de)
DK (2) DK118660B (de)
FR (1) FR6852M (de)
NL (1) NL142677B (de)
SE (1) SE324154B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30014E (en) * 1966-12-09 1979-05-29 Egyesult Gyogyazer-es Tapozergyar 1-(3,4-Dimethoxy-phenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5H-2,3-benzodiazepine
HU179018B (en) * 1978-10-19 1982-08-28 Gyogyszerkutato Intezet Process for producing new 5h-2,3-benzodiazepine derivatives
HU186760B (en) * 1981-03-12 1985-09-30 Gyogyszerkutato Intezet Process for preparing 3,4-dihydro-5h-2,3-aenzodiazepine derivatives
HU191698B (en) * 1984-07-27 1987-03-30 Gyogyszerkutato Intezet Process for producing new 1-aryl-5h-2beta-benzodiazepines
HU195788B (en) * 1986-05-21 1988-07-28 Gyogyszerkutato Intezet Process for producing 1-/hydroxy-stiryl/-5h-2,3-benzobiazepines and pharmaceutical compositions containing them
HUP9701284A3 (en) * 1997-07-24 2005-11-28 Egyt Gyogyszervegyeszeti Gyar Use of 2,3-benzodiazepine derivatives for producing pharmaceutical compositions for treating and prophylacting illnesses and conditions connected with the endogene opioide system
ATE269705T1 (de) * 1998-10-27 2004-07-15 Vela Pharmaceuticals Inc Verwendung von optisch reinem (r)-tofizopam zur behandlung und pravention von angststörungen
US6080736A (en) * 1999-10-27 2000-06-27 Janus Pharmaceuticals, Inc. Methods and compositions for treating and preventing anxiety and anxiety disorders using optically pure (R) tofisopam
FR2824065A1 (fr) * 2001-04-26 2002-10-31 Neuro3D Composes inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations
US6649607B2 (en) * 2001-05-18 2003-11-18 Vela Pharmaceuticals, Inc. Compositions and methods for treating or preventing convulsions or seizures
US6638928B1 (en) 2002-12-03 2003-10-28 Vela Pharmaceuticals, Inc. Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines
US7022700B2 (en) * 2002-12-03 2006-04-04 Vela Pharmaceuticals, Inc. Method of increasing neutrophil production using optically-pure (R)-2,3-benzodiazepines
US20040152695A1 (en) * 2002-12-03 2004-08-05 Vela Pharmaceuticals, Inc. Pharmaceutical composition of 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5H-2,3-benzodiazepine and uses thereof
CA2508542A1 (en) * 2002-12-03 2004-06-17 Vela Pharmaceuticals, Inc. Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5h-2,3-benzodiazepine and uses thereof
US6864251B2 (en) * 2002-12-03 2005-03-08 Vela Pharmaceuticals, Inc. Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepines
US20040224943A1 (en) * 2003-02-19 2004-11-11 Leventer Steven M. Method of lowering body temperature with (R) - 2,3-benzodiazepines
US20040162284A1 (en) * 2003-02-19 2004-08-19 Harris Herbert W. Method of lowering body temperature with (S) tofisopam
CA2525273C (en) * 2003-05-16 2012-04-17 Vela Pharmaceuticals, Inc. Treatment of gastrointestinal dysfunction and related stress with an enantiomerically-pure (r) 2,3-benzodiazepine
US20070021412A1 (en) * 2003-05-16 2007-01-25 Vela Pharmaceuticals, Inc. Treatment of gastrointestinal dysfunction and related stress with an enantiomerically-pure (S) 2,3-benzodiazepine
US20050288277A1 (en) * 2004-06-25 2005-12-29 Kucharik Robert F Treatment of gastrointestinal dysfunction and related stress with an enantiomerically-pure (S)-2,3-benzodiazepine
US20040254173A1 (en) * 2003-06-13 2004-12-16 Leventer Steven M. Modulation of dopamine responses with substituted (S)-2,3-benzodiazepines
FR2870539B1 (fr) * 2004-05-19 2006-08-04 Greenpharma Sa Sa Nouvelles methodes et medicaments
US7541355B2 (en) * 2005-05-23 2009-06-02 Vela Acquisition Corporation Conversion process for 2,3-benzodiazepine enantiomers
CN107915688A (zh) * 2016-10-09 2018-04-17 北京阜康仁生物制药科技有限公司 一种托非索泮的合成工艺改进方法

Also Published As

Publication number Publication date
NL6716753A (de) 1968-06-10
AT279618B (de) 1970-03-10
AT279617B (de) 1970-03-10
FR6852M (de) 1969-04-08
AT278797B (de) 1970-02-10
DK118660B (da) 1970-09-21
DE1670642B2 (de) 1978-09-07
DE1670642C3 (de) 1979-05-03
NL142677B (nl) 1974-07-15
SE324154B (de) 1970-05-25
DK125650B (da) 1973-03-19
US3736315A (en) 1973-05-29
BE707730A (de) 1968-04-16
DE1670642A1 (de) 1971-03-18

Similar Documents

Publication Publication Date Title
CH494222A (de) Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
CH548365A (de) Verfahren zur herstellung von 3,4-dihydroxy-oder 3,4diocyloxyphenylalkanolaminen.
CH519507A (de) Verfahren zur Herstellung von neuem 1-Veratryl-4-methyl-5-äthyl-7,8-dimethoxy-2,3-diazabicyclo(5.4.0)-undecapentaen-(1,3,6,8,10)
AT271479B (de) Verfahren zur Herstellung von 2,4-Diamino-5-benzylpyrimidinen
CH481924A (de) Verfahren zur Herstellung von 6-Aminophenyl- und 6-Acylaminophenyl-4,5-dihydropyridazonen (3)
CH478828A (de) Verfahren zur Herstellung von neuen substituierten 3,1-Benzoxazin-2-onen
CH449011A (de) Verfahren zur Herstellung von 2,3-Pyridindiol
CH485775A (de) Verfahren zur Herstellung von 9-B-D-Ribofuranosyl-7-deazapurin-3',5'-cyclophosphaten
CH487096A (de) Verfahren zur Herstellung von 4,4'-Dohydroxy-stilbenen
CH481935A (de) Verfahren zur Herstellung von N-Acyl-3,4-dihydrooxazinen-(1,3)
CH506548A (de) Verfahren zur Herstellung von 2-aminsubstituiertem 4,5-Diphenyl-Oxazol
AT275758B (de) Verfahren zur Herstellung von neuen 4-Oxa-9β,10α-Steroiden
AT275060B (de) Verfahren zur Herstellung von 1β-Hydroxy-5-oxo-4-(2'-carboxy-äthyl)-7aβ-R-3aα-4β,5,6,7,7a-hexahydroindanen
CH484856A (de) Verfahren zur Herstellung von 3,3-Alkylendioxy- oder 3,3-Dialkoxy-alkylhalogeniden
AT277240B (de) Verfahren zur Herstellung von 6-Styryl-5,6-dihydro-α-pyronen
AT259771B (de) Verfahren zur Herstellung von 6,7-Benzomorphanen
CH490299A (de) Verfahren zur Herstellung von Diaryl-8-methoxy-1,2,3,4-tetrahydro-1,2-naphthalindiolen
CH490342A (de) Verfahren zur Herstellung von 2,6-Dicyan-4-nitranilin
CH475264A (de) Verfahren zur Herstellung von 2-Arylamino-4,6-dichlor-s-triazinen
CH478780A (de) Verfahren zur Herstellung von 3a,5-Cyclo-6B,19-oxido-5a-androstan-17-on.
AT266800B (de) Verfahren zur Herstellung von 2-Thiapropandiol-(1,3)
CH483434A (de) Verfahren zur Herstellung von 1,2-Dihydrobenzodiazepinen
CH498118A (de) Verfahren zur Herstellung von 2-Amidino-1,2,3,4-tetrahydroisochinolinen
AT292662B (de) Verfahren zur Herstellung von 1,1'-Peroxydicyclohexylamin
CH521361A (de) Verfahren zur Herstellung von neuen 11-Amino-5,6-dihydro-6-morphanthridonen

Legal Events

Date Code Title Description
PL Patent ceased